Keyphrases
Clinical Setting
100%
Screening for Aneuploidy
100%
Cell-free DNA (cfDNA)
100%
First-trimester Screening
100%
Trisomy 21
84%
Trisomy 18
53%
Trisomy 13
38%
Screening Strategy
23%
Sex Chromosome Aneuploidy
23%
Invasive Tests
23%
Pregnancy-associated Plasma protein-A (PAPP-A)
15%
Invasive Testing
15%
Fetal Fraction
15%
Univariate Analysis
7%
Maternal Blood
7%
Maternal-fetal
7%
Maternal Weight
7%
Chromosome Analysis
7%
Screening Assessment
7%
False Positive Rate
7%
Multivariate Analysis
7%
Screening Performance
7%
Pregnancy Outcome
7%
Fetal Medicine
7%
Blood Samples
7%
Maternal Age
7%
Cell-free DNA Analysis
7%
Human Chorionic Gonadotropin
7%
Fetus
7%
Nuchal Translucency Thickness
7%
Screening Risk Assessment
7%
Female Fetus
7%
Singleton Pregnancy
7%
Medicine and Dentistry
Cell-Free DNA
100%
Aneuploidy
100%
First Trimester Pregnancy
100%
Trisomy 21
84%
Trisomy 18
38%
Trisomy 13
38%
Cell-Free DNA Testing
30%
Patient Referral
23%
Karyotype
15%
Pregnancy-Associated Plasma Protein A
15%
Chromosome Analysis
7%
Multivariate Analysis
7%
Chorionic Gonadotropin
7%
Nuchal Translucency Measurement
7%
Perinatology
7%
False Positive Result
7%
Sex Chromosome Aberration
7%
Maternal Age
7%
Maternal Blood
7%
Univariate Analysis
7%